LUNG Stock Analysis: Buy, Sell, or Hold?
LUNG - Pulmonx Corporation Common Stock
$1.55
0.01 (0.65%)
▲
5d:
+22.05%
30d:
+21.09%
90d:
+4.73%
HOLD
MODERATE Confidence
Analysis Updated: May 22, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Get Alerted When LUNG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: LUNG is 8.4% above its trading range ($1.43). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: LUNG is 8.4% above its trading range ($1.43). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: LUNG is currently trading at $1.55, which is considered extended relative to its 30-day fair value range of $1.24 to $1.43.
Technical Outlook: Technically, LUNG is in a strong downtrend. The price is approaching resistance at $1.56. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LUNG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.17 (+233.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LUNG is in a strong downtrend. The price is approaching resistance at $1.56. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LUNG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.17 (+233.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.24 -
$1.43
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range (+8.4% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 233.3% below Wall St target ($5.17)
- CAUTION: Extended 8.4% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$1.24 -
$1.43
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.18
(11.7%)
Support & Resistance Levels
Support Level
$1.21
Resistance Level
$1.56
Current Trend
Strong Downtrend
Technical data as of
May 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.74
Wall Street Target
$5.17
(+233.3%)
Revenue Growth (YoY)
-8.7%
Profit Margin
-60.1%
Share & Embed Analysis
Last updated: May 25, 2026 5:22 AM ET
Data refreshes hourly during market hours. Next update: 6:22 AM
Data refreshes hourly during market hours. Next update: 6:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LUNG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Geoffrey Beran Rose
SELL
7732 shares
2026-03-02
Glendon E French III
SELL
67813 shares
2026-03-02
Srikanth Radhakrishnan
SELL
10483 shares
2026-03-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$83 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$82 | 64 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 57 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$107 | 62 BUY |
